JP2015500862A5 - - Google Patents

Download PDF

Info

Publication number
JP2015500862A5
JP2015500862A5 JP2014548012A JP2014548012A JP2015500862A5 JP 2015500862 A5 JP2015500862 A5 JP 2015500862A5 JP 2014548012 A JP2014548012 A JP 2014548012A JP 2014548012 A JP2014548012 A JP 2014548012A JP 2015500862 A5 JP2015500862 A5 JP 2015500862A5
Authority
JP
Japan
Prior art keywords
methyl
amino
pyrazol
chloro
pyrrolidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2014548012A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015500862A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/076371 external-priority patent/WO2013092854A1/en
Publication of JP2015500862A publication Critical patent/JP2015500862A/ja
Publication of JP2015500862A5 publication Critical patent/JP2015500862A5/ja
Withdrawn legal-status Critical Current

Links

JP2014548012A 2011-12-23 2012-12-20 キナーゼ阻害剤としてのピリミジン−2,4−ジアミン誘導体 Withdrawn JP2015500862A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11195662 2011-12-23
EP11195662.9 2011-12-23
PCT/EP2012/076371 WO2013092854A1 (en) 2011-12-23 2012-12-20 Pyrimidine-2,4-diamine derivatives as kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2015500862A JP2015500862A (ja) 2015-01-08
JP2015500862A5 true JP2015500862A5 (enExample) 2016-02-18

Family

ID=47429836

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014548012A Withdrawn JP2015500862A (ja) 2011-12-23 2012-12-20 キナーゼ阻害剤としてのピリミジン−2,4−ジアミン誘導体

Country Status (10)

Country Link
US (1) US20150005281A1 (enExample)
EP (1) EP2794598A1 (enExample)
JP (1) JP2015500862A (enExample)
KR (1) KR20140114344A (enExample)
CN (1) CN104169272A (enExample)
AU (1) AU2012357038B2 (enExample)
BR (1) BR112014015723A8 (enExample)
CA (1) CA2860095A1 (enExample)
RU (1) RU2014130214A (enExample)
WO (1) WO2013092854A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9296725B2 (en) * 2012-05-24 2016-03-29 Cellzome Limited Heterocyclyl pyrimidine analogues as TYK2 inhibitors
AR094537A1 (es) * 2013-11-07 2015-08-12 Bristol Myers Squibb Co COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O IFNa
US9260415B2 (en) * 2013-12-05 2016-02-16 Genentech, Inc. Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality
AR099376A1 (es) * 2013-12-20 2016-07-20 Signal Pharm Llc Compuestos de diaminopirimidilo sustituidos, sus composiciones y métodos de tratamiento con aquellos
JP6517319B2 (ja) 2014-03-28 2019-05-22 キャリター・サイエンシーズ・リミテッド・ライアビリティ・カンパニーCalitor Sciences, Llc 置換されたヘテロアリール化合物および使用方法
US10106507B2 (en) 2014-08-03 2018-10-23 H. Lee Moffitt Cancer Center and Research Insitute, Inc. Potent dual BRD4-kinase inhibitors as cancer therapeutics
EP3347097B1 (en) 2015-09-11 2021-02-24 Sunshine Lake Pharma Co., Ltd. Substituted aminopyrimidine derivatives as modulators of the kinases jak, flt3 and aurora
US10738016B2 (en) 2015-10-13 2020-08-11 H. Lee Moffitt Cancer Center And Research Institute, Inc. BRD4-kinase inhibitors as cancer therapeutics
CN113214230B (zh) * 2017-09-21 2022-10-04 北京赛特明强医药科技有限公司 2-取代吡唑氨基-4-取代氨基-5-嘧啶甲酰胺类化合物、组合物及其应用
WO2019057112A1 (zh) * 2017-09-21 2019-03-28 北京赛特明强医药科技有限公司 2-取代吡唑氨基-4-取代氨基-5-嘧啶甲酰胺类化合物、组合物及其应用
CN110734427B (zh) * 2018-07-20 2021-01-15 北京赛特明强医药科技有限公司 含烯基的嘧啶甲酰胺类化合物、组合物及其应用
CN111718332B (zh) * 2019-03-19 2021-08-17 北京赛特明强医药科技有限公司 2-取代吡唑氨基-4-取代氨基-5-嘧啶甲酰胺类化合物、组合物及其应用
CN111004215B (zh) * 2019-12-22 2022-08-09 华北理工大学 2,4-取代嘧啶类衍生物及其制备方法和在制备抗肿瘤药物中的应用
WO2025166161A1 (en) * 2024-02-02 2025-08-07 Deciphera Pharmaceuticals, Llc Ulk inhibitors and methods of use thereof
WO2025166124A1 (en) * 2024-02-02 2025-08-07 Deciphera Pharmaceuticals, Llc Ulk inhibitors and methods of use thereof
CN120698987B (zh) * 2025-06-20 2026-04-17 大连医科大学 2-芳氨基嘧啶类化合物及其应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2280930C (en) 1997-02-12 2010-04-06 The Regents Of The University Of Michigan Protein markers for lung cancer and use thereof
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
BRPI0017548B8 (pt) 1999-02-10 2023-05-02 Astrazeneca Ab Composto
CN100376567C (zh) 1999-11-05 2008-03-26 阿斯特拉曾尼卡有限公司 作为vegf抑制剂的喹唑啉衍生物
EA006227B1 (ru) 1999-12-10 2005-10-27 Пфайзер Продактс Инк. СОЕДИНЕНИЯ ПИРРОЛО[2,3-d]ПИРИМИДИНА
AR034118A1 (es) 2000-02-15 2004-02-04 Sugen Inc Compuestos de 2-indolinonas sustituidas con pirroles inhibidoras de proteinquinasas; sus composiciones farmaceuticas e intermediarios de sintesis
US7109337B2 (en) 2002-12-20 2006-09-19 Pfizer Inc Pyrimidine derivatives for the treatment of abnormal cell growth
EA013248B1 (ru) 2002-12-20 2010-04-30 Пфайзер Продактс Инк. Производные пиримидина для лечения патологического роста клеток
UA80767C2 (en) 2002-12-20 2007-10-25 Pfizer Prod Inc Pyrimidine derivatives for the treatment of abnormal cell growth
ITMI20022758A1 (it) 2002-12-23 2004-06-24 Isagro Ricerca Srl Nuovi uracili ad attivita' erbicida.
WO2005111022A1 (en) 2004-05-14 2005-11-24 Pfizer Products Inc. Pyrimidines derivatives for the treatment of abnormal cell growth
WO2006134056A1 (en) 2005-06-14 2006-12-21 Cellzome Ag Process for the identification of novel enzyme interacting compounds
RS20080272A (sr) 2005-12-21 2009-07-15 Pfizer Products Inc., Derivati pirimidina za tretman neprirodnog rasta ćelija
GB0605691D0 (en) 2006-03-21 2006-05-03 Novartis Ag Organic Compounds
ES2318616T3 (es) 2006-06-01 2009-05-01 Cellzome Ag Metodos para la identificacion de moleculas que interactuan con zap-70 y para la purificacion de zap-70.
EP2054392A2 (en) 2006-06-15 2009-05-06 Boehringer Ingelheim International GmbH 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
CA2657260A1 (en) 2006-07-21 2008-01-24 Novartis Ag 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors
KR20100014271A (ko) 2006-11-16 2010-02-10 파마코페이아, 엘엘씨. 면역 억제를 위한 7-치환된 퓨린 유도체
DE102007010801A1 (de) 2007-03-02 2008-09-04 Bayer Cropscience Ag Diaminopyrimidine als Fungizide
US7947698B2 (en) 2007-03-23 2011-05-24 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the JAK pathway
US7834024B2 (en) 2007-03-26 2010-11-16 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the JAK pathway
AP2009005010A0 (en) 2007-04-18 2009-10-31 Pfizer Prod Inc Sulfonyl amide derivatives for the treatment of abnormal cell growth
JP2010532756A (ja) 2007-07-06 2010-10-14 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド mTORC1及びmTORC2の両方の阻害剤を含む組み合わせ抗癌療法
JP5705720B2 (ja) 2008-04-16 2015-04-22 ポートラ ファーマシューティカルズ, インコーポレイテッド Sykまたはjakキナーゼ阻害剤としての2,6−ジアミノ−ピリミジン−5−イル−カルボキサミド
WO2010025851A1 (de) * 2008-09-03 2010-03-11 Bayer Cropscience Ag Thienylaminopyrimidine als fungizide
CL2009001884A1 (es) 2008-10-02 2010-05-14 Incyte Holdings Corp Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
CA2749195C (en) 2009-01-15 2017-03-07 Rigel Pharmaceuticals, Inc. Protein kinase c inhibitors and uses thereof
US20120040955A1 (en) 2009-04-14 2012-02-16 Richard John Harrison Fluoro substituted pyrimidine compounds as jak3 inhibitors
US8367689B2 (en) 2009-05-06 2013-02-05 Portola Pharmaceuticals, Inc. Inhibitors of JAK
EP2443106A1 (en) * 2009-06-18 2012-04-25 Cellzome Limited Heterocyclylaminopyrimidines as kinase inhibitors
EP2475648A1 (en) 2009-09-11 2012-07-18 Cellzome Limited Ortho substituted pyrimidine compounds as jak inhibitors
NZ598907A (en) 2009-10-20 2014-03-28 Cellzome Ltd Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
MX2012012328A (es) 2010-04-30 2013-05-06 Cellzome Ltd Compuestos pirazol como inhibidores de jak.
EP2588105A1 (en) 2010-07-01 2013-05-08 Cellzome Limited Triazolopyridines as tyk2 inhibitors
WO2012022681A2 (en) 2010-08-20 2012-02-23 Cellzome Limited Heterocyclyl pyrazolopyrimidine analogues as selective jak inhibitors
EP2638018A1 (en) 2010-11-09 2013-09-18 Cellzome Limited Pyridine compounds and aza analogues thereof as tyk2 inhibitors

Similar Documents

Publication Publication Date Title
RU2014130214A (ru) Пиримидин-2, 4-диаминовые производные в качестве ингибиторов киназы
JP2014521623A5 (enExample)
CA2671744A1 (en) Compounds and compositions as protein kinase inhibitors
SI3074386T1 (en) New aminopyrimidine derivatives
JP2012501312A5 (enExample)
AU2010286569B2 (en) Compounds and compositions as protein kinase inhibitors
JP2017510555A5 (enExample)
JP2023509260A5 (enExample)
AU2016314898B2 (en) 2,4-bis(nitrogen-containing group)-substituted pyrimidine compound, preparation method and use thereof
JP2020073561A5 (enExample)
RU2433128C2 (ru) Новые пиримидиновые производные и их применение в терапии, а также применение пиримидиновых производных в изготовлении лекарственного средства для предупреждения и/или лечения болезни альцгеймера
RU2386630C2 (ru) Соединения и композиции в качестве ингибиторов протеинтирозинкиназы
JP2017530999A5 (enExample)
JP2017510554A5 (enExample)
HRP20231310T1 (hr) Heteroarilaminopirimidin amidni inhibitori autofagije i postupci njihove primjene
RU2014152257A (ru) Гетероциклильные пиримидиновые аналоги в качестве ингибиторов tyk2
JP2017506659A5 (enExample)
RU2013155456A (ru) Соединения пирролидинилмочевины и пирролидинилтиомочевины как ингибиторы киназы trka
HRP20110882T1 (hr) Ciklopenta [d] pirimidini kao inhibitori kinaze akt proteina
JP2014526549A5 (enExample)
JP2013510876A5 (enExample)
RU2016136116A (ru) Фармацевтические соединения
HRP20172006T1 (hr) Derivati pirazol-aminopiridina kao lrrk2-modulatori
JP2009513575A5 (enExample)
SI2790705T1 (en) Use of activity inhibitors or PI3K function